Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

6.55
Delayed Data
As of Oct 20
 -0.02 / -0.30%
Today’s Change
6.41
Today|||52-Week Range
13.80
-22.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$122.2M

Company Description

Novelion Therapeutics, Inc. develops and markets ocular products. It is engaged in developing new standards of care for individuals living with rare diseases. The company is headquartered in Vancouver, Canada.

Contact Information

Novelion Therapeutics, Inc.
510 West Georgia Street
Vancouver British Columbia V6B 0M3
P:(617) 500-7867
Investor Relations:

Employees

Shareholders

Other institutional71.83%
Individual stakeholders13.59%
Mutual fund holders10.37%

Top Executives

Mary J. SzelaChief Executive Officer & Director
Gregory D. PerryChief Financial & Administrative Officer
Roger W. LouisChief Compliance Officer
Linda BuonoSenior Vice President-Human Resources
Ben HarshbargerGeneral Counsel